Seventy-first World Health Assembly (A71/1)

Provisional agenda

11.
Strategic priority matters
11.1
Draft thirteenth general programme of work, 2019–2023
11.2
Public health preparedness and response
11.3
Polio transition and post-certification
11.4
Health, environment and climate change
11.5
Addressing the global shortage of, and access to, medicines and vaccines
11.6
Global strategy and plan of action on public health, innovation and intellectual property
11.7
Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018
11.8
Preparation for a high-level meeting of the General Assembly on ending tuberculosis
12.
Other technical matters
12.1
Global snakebite burden
12.2
Physical activity for health
12.3
Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030): sexual and reproductive health, interpersonal violence, and early childhood development
12.4
mHealth
12.5
Improving access to assistive technology
12.6
Maternal, infant and young child nutrition
12.7
Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits
12.8
Rheumatic fever and rheumatic heart disease
12.9
Eradication of poliomyelitis
12.I0
Multilingualism: implementation of action plan (resolution WHA61.12 (2008))
20.
Matters for information
20.1
Global vaccine action plan
20.3
Progress reports
20.3.1
Communicable diseases
20.3.1.1
A. Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, for the period 2016–2021 (resolution WHA69.22 (2016))
20.3.1.2
B. Eradication of dracunculiasis (resolution WHA64.16 (2011))
20.3.1.3
C. Elimination of schistosomiasis (resolution WHA65.21 (2012))
20.3.2
Noncommunicable diseases
20.3.2.1
D. Public health dimension of the world drug problem (decision WHA70(18) (2017))
20.3.2.2
E. WHO global plan of action to strengthen the role of the health system within a national multisectoral response to address interpersonal violence, in particular against women and girls, and against children (resolution WHA69.5 (2016))
20.3.2.3
F. Global burden of epilepsy and the need for coordinated action at the country level to address its health, social and public knowledge implications (resolutionWHA68.20 (2015))
20.3.2.4
G. Comprehensive mental health action plan 2013−2020 (resolution WHA66.8 (2013))
20.3.2.5
H. Comprehensive and coordinated efforts for the management of autism spectrum disorders (resolution WHA67.8 (2014))
20.3.3
Promoting health through the life course
20.3.3.1
I. Global strategy and action plan on ageing and health 2016–2020: towards a world in which everyone can live a long and healthy life (resolution WHA69.3 (2016))
20.3.3.2
J. Reproductive health: strategy to accelerate progress towards the attainment of international development goals and targets (resolution WHA57.12 (2004))
20.3.4
Health systems
20.3.4.1
K. Promoting the health of refugees and migrants (resolution WHA70.15 (2017))
20.3.4.2
L. Strengthening integrated, people-centred health services (resolution WHA69.24 (2016))
20.3.4.3
M. Promoting innovation and access to quality, safe, efficacious and affordable medicines for children (resolution WHA69.20 (2016))
20.3.4.4
N. Sustainable health financing structures and universal coverage (resolution WHA64.9 (2011))
20.3.4.5
O. Availability, safety and quality of blood products (resolution WHA63.12 (2010))
20.3.4.6
P. Human organ and tissue transplantation (resolution WHA63.22 (2010))
20.3.4.7
Q. WHO strategy on research for health (resolution WHA63.21 (2010))
20.3.4.8
R. Workers’ health: global plan of action (resolution WHA60.26 (2007))
20.3.5
Health emergencies programme
20.3.5.1
S. Smallpox eradication: destruction of variola virus stocks (resolution WHA60.1 (2007))